Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6849951rdf:typepubmed:Citationlld:pubmed
pubmed-article:6849951lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:6849951lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:6849951lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:6849951lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:6849951lifeskim:mentionsumls-concept:C0021853lld:lifeskim
pubmed-article:6849951lifeskim:mentionsumls-concept:C0103839lld:lifeskim
pubmed-article:6849951lifeskim:mentionsumls-concept:C0205666lld:lifeskim
pubmed-article:6849951lifeskim:mentionsumls-concept:C0728940lld:lifeskim
pubmed-article:6849951lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:6849951lifeskim:mentionsumls-concept:C0015252lld:lifeskim
pubmed-article:6849951lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:6849951pubmed:issue3lld:pubmed
pubmed-article:6849951pubmed:dateCreated1983-7-8lld:pubmed
pubmed-article:6849951pubmed:abstractTextApolipoprotein B, the major structural protein of triacylglycerol-rich lipoprotein, occurs in two immunologically distinct forms, termed apolipoproteins B-100 and B-48. In man, the former is associated with triacylglycerol-rich lipoproteins of hepatic origin and the latter with intestinal triacylglycerol-rich lipoproteins. We have studied the rates of removal of the two proteins when 125I-labelled triacylglycerol-rich lipoproteins were reinjected into six severely hypertriglyceridemic subjects showing hyperchylomicronemia, and into two normal subjects. The specific radioactivities of apolipoproteins B-100 and B-48 were determined over periods of up to 30 h. In all six hyperlipemic subjects the removal of apolipoprotein B-100 was either significantly faster than that of apolipoprotein B-48 (in four) or similar in the two who cleared triacylglycerol-rich lipoproteins very slowly. When triacylglycerol-rich lipoproteins from two hyperlipemic subjects (in whom apolipoprotein B-48 was cleared more slowly) were injected into two normal subjects both B apolipoproteins were cleared at similar rates. Since apolipoprotein B-48 appears to be a marker for remnants of intestinal particles, its slower removal than that of apolipoprotein B-100 in severe hypertriglyceridemia suggests that one metabolic defect associated with the hyperchylomicronemia is defective removal of chylomicron remnants.lld:pubmed
pubmed-article:6849951pubmed:languageenglld:pubmed
pubmed-article:6849951pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6849951pubmed:citationSubsetIMlld:pubmed
pubmed-article:6849951pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6849951pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6849951pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6849951pubmed:statusMEDLINElld:pubmed
pubmed-article:6849951pubmed:monthMaylld:pubmed
pubmed-article:6849951pubmed:issn0006-3002lld:pubmed
pubmed-article:6849951pubmed:authorpubmed-author:BillingtonTTlld:pubmed
pubmed-article:6849951pubmed:authorpubmed-author:NestelP JPJlld:pubmed
pubmed-article:6849951pubmed:authorpubmed-author:FidgeN HNHlld:pubmed
pubmed-article:6849951pubmed:issnTypePrintlld:pubmed
pubmed-article:6849951pubmed:day16lld:pubmed
pubmed-article:6849951pubmed:volume751lld:pubmed
pubmed-article:6849951pubmed:ownerNLMlld:pubmed
pubmed-article:6849951pubmed:authorsCompleteYlld:pubmed
pubmed-article:6849951pubmed:pagination422-7lld:pubmed
pubmed-article:6849951pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:meshHeadingpubmed-meshheading:6849951-...lld:pubmed
pubmed-article:6849951pubmed:year1983lld:pubmed
pubmed-article:6849951pubmed:articleTitleSlower removal of intestinal apolipoprotein B-48 than of apolipoprotein B-100 in severely hypertriglyceridemic subjects.lld:pubmed
pubmed-article:6849951pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6849951pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6849951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6849951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6849951lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6849951lld:pubmed